CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
Authors
Jonathan Assayag
Laurent Azoulay
+5 more
Kristian B Filion
Agnieszka Majdan
Michael N Pollak
Samy Suissa
Hui Yin
Publication date
Publisher
BMJ Publishing Group Ltd.
Doi
Cite
View
on
PubMed
Abstract
Objective To determine if the use of pioglitazone is associated with an increased risk of incident bladder cancer in people with type 2 diabetes
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1136%2Fbmj.e3645
Last time updated on 03/12/2019
